In-silico Methods of Drug Design: Molecular Simulations and Free Energy Calculations
The main aim of in silico drug design approaches is to take the best chemical substances to wet laboratory investigation through the reduction of cost and last stage attrition. In silico drug design approaches can utilize natural products and their semi-synthetic derivatives as starting material for discovery/design of small molecule drugs. The application of computers and computational approaches help in all areas of drug discovery and create the core of structure-based drug design.
We would like to thank Central University of Punjab, Bathinda, Punjab, (India) and Director in-charge, National Institute of Pathology, New Delhi (India) for supporting this study with infrastructural requirements. This study was also supported by a Centenary-Post Doctoral Research Fellowship Grant-in-Aid from the Indian Council of Medical Research (ICMR), Government of India awarded to PS.
Conflict of Interest
The authors declare that no financial or commercial conflict of interest.
- Barlow DH, Nock M, Hersen M. Single case experimental designs: strategies for studying behavior for change. Boston: Pearson/Allyn and Bacon; 2009.Google Scholar
- Changeux JP, Edelstein S. Conformational selection or induced fit? 50 years of debate resolved. F1000 Biol Rep. 2011;3:1–15.Google Scholar
- de Amorim HL, Caceres RA, Netz PA. Linear interaction energy (LIE) method in lead discovery and optimization. Curr Drug Targets. 2008;9(12):1100–5.Google Scholar
- Guner OF. Pharmacophore perception, development, and use in drug design. La Jolla: International University Line; 2000. p. 29.Google Scholar
- Nair PC, Miners JO. Molecular dynamics simulations: from structure function relationships to drug discovery. In Silico Pharmacol. 2014;2(1):1–4.Google Scholar
- Singh P, Bast F, Singh R. Natural compounds targeting transforming growth factor-β: in silico and in vitro study. Elect J Biol. 2016;13:6–13.Google Scholar
- Singh P, Kumar S, Bast F. Natural compounds are smart players in context to anticancer potential of receptor tyrosine kinases: an in silico and in vitro advancement. In: Wei DQ, Ma Y, Cho W, Xu Q, Zhou F, editors. Translational bioinformatics and its application. Dordrecht: Springer; 2017. p. 177–202.CrossRefGoogle Scholar
- Tao H, Chu ZT, Warshel A. Quantitative studies of ligand-receptor interactions: a rapid evaluation of binding free energies of endothiapepsin to its inhibitors. Pac Symp Biocomput. 1996:752–5.Google Scholar